The protective role of TIMP2 in TBI implies that TIMP2 has the potential to be a therapeutic agent for CNS disorders involving BBB sealing deficiency and that the α3β1 integrin/Src/VEC/Rac1 pathway regulated by TIMP2 is a potential therapeutic target for alleviating BBB damage. Here, RAC1 is linked to central nervous system disorder.